Literature DB >> 11461118

Effects of HsRad51 overexpression on cell proliferation, cell cycle progression, and apoptosis.

J Flygare1, S Fält, J Ottervald, J Castro, D Hellgren, A Wennborg.   

Abstract

Expression of the DNA repair and recombination protein human Rad51 (HsRad51) is increased in transformed cells and in cancer cell lines. In order to study the effects of acute HsRad51 ectopic overexpression on cell proliferation, cell cycle progression, and apoptosis, we generated clones of the human fibrosarcoma cell line HT1080 carrying a HsRad51 transgene under a repressible promoter. The HsRad51-overexpressing cells showed decreased plating efficiency and growth rate in a dose-dependent manner with regard to the degree of overexpression. An accumulation of HsRad51-overexpressing cells in G(2) was observed following release of cells after synchronization with double thymidine block. Moreover, the fraction of apoptotic cells measured by annexin V-FACS increased with the time of HsRad51 overexpression. In the light of these observations, sustained increased levels of HsRad51 may contribute to tumor progression by causing a selection for cells tolerant to the growth-suppressive and apoptosis-inducing effects of acute HsRad51 overexpression. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461118     DOI: 10.1006/excr.2001.5265

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors.

Authors:  Jiewen Zhu; Hongyuan Chen; Xuning Emily Guo; Xiao-Long Qiu; Chun-Mei Hu; A Richard Chamberlin; Wen-Hwa Lee
Journal:  Eur J Med Chem       Date:  2015-04-09       Impact factor: 6.514

Review 2.  The consequences of Rad51 overexpression for normal and tumor cells.

Authors:  Hannah L Klein
Journal:  DNA Repair (Amst)       Date:  2008-02-01

3.  The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors.

Authors:  Jennifer M Mason; Hillary L Logan; Brian Budke; Megan Wu; Michal Pawlowski; Ralph R Weichselbaum; Alan P Kozikowski; Douglas K Bishop; Philip P Connell
Journal:  Cancer Res       Date:  2014-04-21       Impact factor: 12.701

4.  Association between RAD 51 rs1801320 and susceptibility to glioblastoma.

Authors:  S Franceschi; S Tomei; C M Mazzanti; F Lessi; P Aretini; M La Ferla; V De Gregorio; F Pasqualetti; K Zavaglia; G Bevilacqua; A G Naccarato
Journal:  J Neurooncol       Date:  2015-10-28       Impact factor: 4.130

Review 5.  Contributions of Rad9 to tumorigenesis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

6.  Determination of the number of RAD51 molecules in different human cell lines.

Authors:  Franziska Foertsch; Tom Kache; Sebastian Drube; Christoph Biskup; Heinz Peter Nasheuer; Christian Melle
Journal:  Cell Cycle       Date:  2019-11-15       Impact factor: 4.534

7.  RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.

Authors:  Ulrica K Westermark; Nanna Lindberg; Pernilla Roswall; Daniel Bråsäter; Hildur R Helgadottir; Sanna-Maria Hede; Anders Zetterberg; Maria Jasin; Monica Nistér; Lene Uhrbom
Journal:  Neuro Oncol       Date:  2011-09-16       Impact factor: 12.300

8.  Overexpression of Drosophila Rad51 protein (DmRad51) disrupts cell cycle progression and leads to apoptosis.

Authors:  Siuk Yoo; Bruce D McKee
Journal:  Chromosoma       Date:  2004-07-15       Impact factor: 4.316

9.  ATM modulates the loading of recombination proteins onto a chromosomal translocation breakpoint hotspot.

Authors:  Jiying Sun; Yukako Oma; Masahiko Harata; Kazuteru Kono; Hiroki Shima; Aiko Kinomura; Tsuyoshi Ikura; Hidekazu Suzuki; Shuki Mizutani; Roland Kanaar; Satoshi Tashiro
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 10.  Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability.

Authors:  David Schild; Claudia Wiese
Journal:  Nucleic Acids Res       Date:  2009-11-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.